Lombard-Bohas C - Search Results

1

Phase II study evaluating the association of gemcitabine, trastuzumab and erlotinib as first-line treatment in patients with metastatic pancreatic adenocarcinoma (GATE 1).

Assenat E, Mineur L, Mollevi C, Lopez-Crapez E, Lombard-Bohas C, Samalin E, Portales F, Walter T, de Forges H, Dupuy M, Boissière-Michot F, Ho-Pun-Cheung A, Ychou M, Mazard T. Assenat E, et al. Int J Cancer. 2021 Feb 1;148(3):682-691. doi: 10.1002/ijc.33225. Epub 2020 Sep 2. Int J Cancer. 2021. PMID: 33405269 Free article. Clinical Trial.

2

[Locally advanced adenocarcinoma of the pancreas: current therapeutic modalities].

Lombard-Bohas C, Mornex F, Saurin JC. Lombard-Bohas C, et al. Cancer Radiother. 1997;1(5):547-54. doi: 10.1016/s1278-3218(97)89637-0. Cancer Radiother. 1997. PMID: 9587388 Review. French.

3

Well-differentiated endocrine carcinoma of the renal pelvis: report of a case with sustained objective response to octreotide.

Walter T, Mege-Lechevallier F, Scoazec JY, Martin X, Chayvialle JA, Lombard-Bohas C. Walter T, et al. Pathol Res Pract. 2009;205(3):183-7. doi: 10.1016/j.prp.2008.10.001. Epub 2008 Nov 28. Pathol Res Pract. 2009. PMID: 19041194

4

Major hyperghrelinemia in advanced well-differentiated neuroendocrine carcinomas: report of three cases.

Walter T, Chardon L, Hervieu V, Cohen R, Chayvialle JA, Scoazec JY, Lombard-Bohas C. Walter T, et al. Eur J Endocrinol. 2009 Oct;161(4):639-45. doi: 10.1530/EJE-09-0073. Epub 2009 Jul 15. Eur J Endocrinol. 2009. PMID: 19605542

5

Sorafenib-induced bilateral osteonecrosis of femoral heads.

Guillet M, Walter T, Scoazec JY, Vial T, Lombard-Bohas C, Dumortier J. Guillet M, et al. J Clin Oncol. 2010 Jan 10;28(2):e14. doi: 10.1200/JCO.2009.23.4252. Epub 2009 Nov 2. J Clin Oncol. 2010. PMID: 19884542 No abstract available.

6

Complete response of hepatocellular carcinoma with systemic combination chemotherapy: not to get out the chemotherapy?

Boschetti G, Walter T, Hervieu V, Cassier P, Lombard-Bohas C, Adham M, Scoazec JY, Dumortier J. Boschetti G, et al. Eur J Gastroenterol Hepatol. 2010 Aug;22(8):1015-8. doi: 10.1097/MEG.0b013e328336565a. Eur J Gastroenterol Hepatol. 2010. PMID: 20075738

7

Outcome of patients receiving chemotherapy for advanced biliary tract or gallbladder carcinoma.

Cassier PA, Thevenet C, Walter T, Baulieux J, Scoazec JY, Bancel B, Adham M, Souquet JC, Ponchon T, Lombard-Bohas C. Cassier PA, et al. Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1111-7. doi: 10.1097/MEG.0b013e3283396dde. Eur J Gastroenterol Hepatol. 2010. PMID: 20386107

8

Evaluation of the combination 5-fluorouracil, dacarbazine, and epirubicin in patients with advanced well-differentiated neuroendocrine tumors.

Walter T, Bruneton D, Cassier PA, Hervieu V, Pilleul F, Scoazec JY, Chayvialle JA, Lombard-Bohas C. Walter T, et al. Clin Colorectal Cancer. 2010 Oct;9(4):248-54. doi: 10.3816/CCC.2010.n.037. Clin Colorectal Cancer. 2010. PMID: 20920998

9

Acute pancreatitis after transcatheter arterial chemoembolization for liver metastases of carcinoid tumors.

Chey V, Chopin-laly X, Micol C, Lepiliez V, Forestier J, Lombard-bohas C, Walter T. Chey V, et al. Clin Res Hepatol Gastroenterol. 2011 Sep;35(8-9):583-5. doi: 10.1016/j.clinre.2010.12.006. Epub 2011 Feb 11. Clin Res Hepatol Gastroenterol. 2011. PMID: 21316325

10

Primary malignant solid pseudopapillary tumors of the gastroduodenal area.

Walter T, Hommell-Fontaine J, Hervieu V, Adham M, Poncet G, Dumortier J, Lombard-Bohas C, Scoazec JY. Walter T, et al. Clin Res Hepatol Gastroenterol. 2011 Mar;35(3):227-33. doi: 10.1016/j.clinre.2011.01.004. Epub 2011 Feb 22. Clin Res Hepatol Gastroenterol. 2011. PMID: 21345760

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page